Help Us in Our Mission to Create a Healthier World
With Series A funding, Uvax Bio has advanced 2 high-priority programs to the IND-preparation stage. There is over $10M of NIH funding in place to support the GMP-production of our HIV-1 vaccine candidate through clinical trials, and we have established contract manufacturing and research partnerships for continued clincial advancement. Get in touch to learn more about partnership and investment opportunites.
